Barely Significant
← all excerpts

NeuproGemp, a polyphenol-rich botanical formula, ameliorates Alzheimer's-like pathology in APP/PS1 mice via inhibition of human glutaminyl cyclase.

Front Pharmacol · 2025 · PMC12582971 · PMID 41194875

2
hedged sentences
closest p
boldest claim

The sentences

0.55 ± 0.15) ( Figure 1C ), indicating a trend toward enhanced recognition memory that did not reach statistical significance under current experimental conditions.

also in 111,027 other papers

highly significantno p-value reported
3 Results 3.1 NeuproGemp improves ethological behavior in APP/PS1 mice In 5-month-old APP/PS1 transgenic mice, 6 weeks of daily oral NeuproGemp treatment (300 mg/kg/day) ( Figure 1A ) led to a marked improvement in ethologically relevant behavior, as shown in the burrowing assay: NeuproGemp-treated mice displaced ∼150 ± 25 g of substrate compared to ∼60 ± 40 g in vehicle controls—a highly significant enhancement ( Figure 1B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.